|
HIV Infection in Homosexual and Bisexual Men Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on HIV Infection in Homosexual and Bisexual Men conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. HIV Infection in Homosexual and Bisexual Men Clinical research trials and HIV Infection in Homosexual and Bisexual Men healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including HIV Infection in Homosexual and Bisexual Men. HIV Infection in Homosexual and Bisexual Men Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a HIV Infection in Homosexual and Bisexual Men clinical trial. Test subjects typically receive the most effective healthcare possible for their HIV Infection in Homosexual and Bisexual Men condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > HIV Infection in Homosexual and Bisexual Men HIV Infection in Homosexual and Bisexual Men
HIV Infection in Homosexual and Bisexual Men
For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: This is a comprehensive observational study of HIV infection in homosexual and bisexual men.
Details: The Multicenter AIDS Cohort Study (MACS) provides important information about the changing nature of HIV-mediated disease progression, the impact of antiretroviral treatment, the nature of HIV pathogenesis, and viral and host genetic factors. This study will also assess the long-term patterns of therapy use and risk-taking behaviors. Patients will have study visits every 6 months. The visits will include interviews, specimen collection, and a physical examination.
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Defined Population, Prospective Study
Minimum Age/Maximum Age: 18 Years/
Genders: Male
Protocol Entry Criteria: Inclusion Criteria: - HIV negative, or - HIV positive and no history or current use of highly active antiretroviral therapy (HAART), or - HIV positive HAART recipient with documentation of HAART initiation, no AIDS diagnosis prior to HAART initiation, and a CD4 cell count and HIV-1 RNA measurement within 6 months prior to first HAART use. - Sexual intercourse with men or at least 5 male or female partners in the 5 years prior to enrollment. Exclusion Criteria: - Injection drug use within 1 year of enrollment. - Perinatally acquired HIV infection.
Total Enrollment: 1100
Location and Contact Information:
University of Pittsburgh School of Public Health
Pittsburgh, Pennsylvania,
United States
Johns Hopkins School of Public Health
Baltimore, Maryland,
United States
Howard Brown Health Center
Chicago, Illinois,
United States
Public Health Center
Los Angeles, California,
United States
Additional Information:
Study ID Numbers: MACS;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00046280
Other Hiv Infections Studies:
1. Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
2. A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients with CD4 Cell Counts of at Least 350 Cells/mm3
3. Double-Blind Comparison of the Efficacy of Continued Zidovudine versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment with Zidovudine
4. A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides
5. A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection
Related Studies:
Other HIV Infections Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials
HIV Infection in Homosexual and Bisexual Men
|
|
|
|
|
|
|
|